nodes	percent_of_prediction	percent_of_DWPC	metapath
Gallamine Triethiodide—Thyroiditis—Imiquimod—skin cancer	0.0591	0.0591	CcSEcCtD
Gallamine Triethiodide—Odynophagia—Docetaxel—skin cancer	0.0326	0.0326	CcSEcCtD
Gallamine Triethiodide—Infertility—Temozolomide—skin cancer	0.0236	0.0236	CcSEcCtD
Gallamine Triethiodide—Neoplasm malignant—Vismodegib—skin cancer	0.0228	0.0228	CcSEcCtD
Gallamine Triethiodide—Common cold—Fluorouracil—skin cancer	0.0217	0.0217	CcSEcCtD
Gallamine Triethiodide—Eyelid oedema—Imiquimod—skin cancer	0.0203	0.0203	CcSEcCtD
Gallamine Triethiodide—Polyp—Vemurafenib—skin cancer	0.0198	0.0198	CcSEcCtD
Gallamine Triethiodide—Cyst—Vemurafenib—skin cancer	0.018	0.018	CcSEcCtD
Gallamine Triethiodide—Cyst—Imiquimod—skin cancer	0.0153	0.0153	CcSEcCtD
Gallamine Triethiodide—Neoplasm malignant—Vemurafenib—skin cancer	0.0141	0.0141	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Vismodegib—skin cancer	0.0129	0.0129	CcSEcCtD
Gallamine Triethiodide—Tingling sensation—Imiquimod—skin cancer	0.0128	0.0128	CcSEcCtD
Gallamine Triethiodide—Tenderness—Imiquimod—skin cancer	0.0118	0.0118	CcSEcCtD
Gallamine Triethiodide—Eruption—Dactinomycin—skin cancer	0.011	0.011	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Vemurafenib—skin cancer	0.0109	0.0109	CcSEcCtD
Gallamine Triethiodide—Lymphadenopathy—Imiquimod—skin cancer	0.00873	0.00873	CcSEcCtD
Gallamine Triethiodide—Swelling—Imiquimod—skin cancer	0.00844	0.00844	CcSEcCtD
Gallamine Triethiodide—Tenderness—Bleomycin—skin cancer	0.00835	0.00835	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Vismodegib—skin cancer	0.00833	0.00833	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Vemurafenib—skin cancer	0.00747	0.00747	CcSEcCtD
Gallamine Triethiodide—Endocrine disorder—Temozolomide—skin cancer	0.00742	0.00742	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Vismodegib—skin cancer	0.00725	0.00725	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Vismodegib—skin cancer	0.0072	0.0072	CcSEcCtD
Gallamine Triethiodide—Tingling sensation—Fluorouracil—skin cancer	0.00705	0.00705	CcSEcCtD
Gallamine Triethiodide—Numbness—Fluorouracil—skin cancer	0.00683	0.00683	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Vismodegib—skin cancer	0.00675	0.00675	CcSEcCtD
Gallamine Triethiodide—Polyp—Docetaxel—skin cancer	0.00672	0.00672	CcSEcCtD
Gallamine Triethiodide—Eruption—Docetaxel—skin cancer	0.00665	0.00665	CcSEcCtD
Gallamine Triethiodide—Eye irritation—Fluorouracil—skin cancer	0.00663	0.00663	CcSEcCtD
Gallamine Triethiodide—Sensory loss—Fluorouracil—skin cancer	0.00654	0.00654	CcSEcCtD
Gallamine Triethiodide—Tenderness—Fluorouracil—skin cancer	0.00649	0.00649	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00633	0.00633	CcSEcCtD
Gallamine Triethiodide—Cyst—Docetaxel—skin cancer	0.00612	0.00612	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Imiquimod—skin cancer	0.00611	0.00611	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Vismodegib—skin cancer	0.006	0.006	CcSEcCtD
Gallamine Triethiodide—Fatigue—Vismodegib—skin cancer	0.00599	0.00599	CcSEcCtD
Gallamine Triethiodide—Pain—Vismodegib—skin cancer	0.00594	0.00594	CcSEcCtD
Gallamine Triethiodide—Throat sore—Docetaxel—skin cancer	0.00567	0.00567	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Vemurafenib—skin cancer	0.00564	0.00564	CcSEcCtD
Gallamine Triethiodide—Oropharyngeal discomfort—Docetaxel—skin cancer	0.00562	0.00562	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Vemurafenib—skin cancer	0.00561	0.00561	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Temozolomide—skin cancer	0.00556	0.00556	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Vismodegib—skin cancer	0.00549	0.00549	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Imiquimod—skin cancer	0.00518	0.00518	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Imiquimod—skin cancer	0.00516	0.00516	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Imiquimod—skin cancer	0.00515	0.00515	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Vemurafenib—skin cancer	0.00515	0.00515	CcSEcCtD
Gallamine Triethiodide—Asthenia—Vismodegib—skin cancer	0.00498	0.00498	CcSEcCtD
Gallamine Triethiodide—Pruritus—Vismodegib—skin cancer	0.00491	0.00491	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Imiquimod—skin cancer	0.00481	0.00481	CcSEcCtD
Gallamine Triethiodide—Eye irritation—Docetaxel—skin cancer	0.00479	0.00479	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Vismodegib—skin cancer	0.00475	0.00475	CcSEcCtD
Gallamine Triethiodide—Swelling—Fluorouracil—skin cancer	0.00466	0.00466	CcSEcCtD
Gallamine Triethiodide—Cough—Vemurafenib—skin cancer	0.00459	0.00459	CcSEcCtD
Gallamine Triethiodide—Oropharyngeal pain—Docetaxel—skin cancer	0.0045	0.0045	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Vemurafenib—skin cancer	0.00448	0.00448	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—skin cancer	0.00445	0.00445	CcSEcCtD
Gallamine Triethiodide—Vomiting—Vismodegib—skin cancer	0.00442	0.00442	CcSEcCtD
Gallamine Triethiodide—Rash—Vismodegib—skin cancer	0.00438	0.00438	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Vismodegib—skin cancer	0.00438	0.00438	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Bleomycin—skin cancer	0.00434	0.00434	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Vemurafenib—skin cancer	0.00417	0.00417	CcSEcCtD
Gallamine Triethiodide—Nausea—Vismodegib—skin cancer	0.00413	0.00413	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Fluorouracil—skin cancer	0.00411	0.00411	CcSEcCtD
Gallamine Triethiodide—Angioedema—Imiquimod—skin cancer	0.0041	0.0041	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Dactinomycin—skin cancer	0.00405	0.00405	CcSEcCtD
Gallamine Triethiodide—Malaise—Imiquimod—skin cancer	0.00404	0.00404	CcSEcCtD
Gallamine Triethiodide—Cough—Imiquimod—skin cancer	0.00391	0.00391	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00391	0.00391	CcSEcCtD
Gallamine Triethiodide—Chest pain—Imiquimod—skin cancer	0.00382	0.00382	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Imiquimod—skin cancer	0.00382	0.00382	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Imiquimod—skin cancer	0.00379	0.00379	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Vemurafenib—skin cancer	0.0037	0.0037	CcSEcCtD
Gallamine Triethiodide—Fatigue—Vemurafenib—skin cancer	0.0037	0.0037	CcSEcCtD
Gallamine Triethiodide—Neoplasm—Docetaxel—skin cancer	0.0037	0.0037	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Bleomycin—skin cancer	0.00368	0.00368	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Fluorouracil—skin cancer	0.00368	0.00368	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Temozolomide—skin cancer	0.00366	0.00366	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Bleomycin—skin cancer	0.00366	0.00366	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Bleomycin—skin cancer	0.00364	0.00364	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Imiquimod—skin cancer	0.00357	0.00357	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Imiquimod—skin cancer	0.00355	0.00355	CcSEcCtD
Gallamine Triethiodide—Eosinophilia—Fluorouracil—skin cancer	0.00352	0.00352	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Vemurafenib—skin cancer	0.00339	0.00339	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Fluorouracil—skin cancer	0.00337	0.00337	CcSEcCtD
Gallamine Triethiodide—Swelling—Docetaxel—skin cancer	0.00336	0.00336	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00333	0.00333	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Imiquimod—skin cancer	0.00329	0.00329	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Vemurafenib—skin cancer	0.00316	0.00316	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Imiquimod—skin cancer	0.00316	0.00316	CcSEcCtD
Gallamine Triethiodide—Fatigue—Imiquimod—skin cancer	0.00316	0.00316	CcSEcCtD
Gallamine Triethiodide—Pain—Imiquimod—skin cancer	0.00313	0.00313	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Temozolomide—skin cancer	0.0031	0.0031	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Temozolomide—skin cancer	0.00309	0.00309	CcSEcCtD
Gallamine Triethiodide—Asthenia—Vemurafenib—skin cancer	0.00308	0.00308	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Temozolomide—skin cancer	0.00307	0.00307	CcSEcCtD
Gallamine Triethiodide—Pruritus—Vemurafenib—skin cancer	0.00304	0.00304	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Imiquimod—skin cancer	0.00302	0.00302	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal haemorrhage—Docetaxel—skin cancer	0.00297	0.00297	CcSEcCtD
Gallamine Triethiodide—Anaemia—Bleomycin—skin cancer	0.00294	0.00294	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Vemurafenib—skin cancer	0.00294	0.00294	CcSEcCtD
Gallamine Triethiodide—Urticaria—Imiquimod—skin cancer	0.00291	0.00291	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Imiquimod—skin cancer	0.00289	0.00289	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Imiquimod—skin cancer	0.00289	0.00289	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Temozolomide—skin cancer	0.00288	0.00288	CcSEcCtD
Gallamine Triethiodide—Malaise—Bleomycin—skin cancer	0.00287	0.00287	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Temozolomide—skin cancer	0.00286	0.00286	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Fluorouracil—skin cancer	0.00286	0.00286	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Bleomycin—skin cancer	0.00285	0.00285	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Fluorouracil—skin cancer	0.00285	0.00285	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Fluorouracil—skin cancer	0.00284	0.00284	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Fluorouracil—skin cancer	0.00283	0.00283	CcSEcCtD
Gallamine Triethiodide—Cough—Bleomycin—skin cancer	0.00278	0.00278	CcSEcCtD
Gallamine Triethiodide—Anaemia—Dactinomycin—skin cancer	0.00275	0.00275	CcSEcCtD
Gallamine Triethiodide—Vomiting—Vemurafenib—skin cancer	0.00273	0.00273	CcSEcCtD
Gallamine Triethiodide—Chest pain—Bleomycin—skin cancer	0.00271	0.00271	CcSEcCtD
Gallamine Triethiodide—Abdominal pain upper—Docetaxel—skin cancer	0.00271	0.00271	CcSEcCtD
Gallamine Triethiodide—Rash—Vemurafenib—skin cancer	0.00271	0.00271	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Vemurafenib—skin cancer	0.0027	0.0027	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Imiquimod—skin cancer	0.0027	0.0027	CcSEcCtD
Gallamine Triethiodide—Headache—Vemurafenib—skin cancer	0.00269	0.00269	CcSEcCtD
Gallamine Triethiodide—Malaise—Dactinomycin—skin cancer	0.00268	0.00268	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Dactinomycin—skin cancer	0.00266	0.00266	CcSEcCtD
Gallamine Triethiodide—Nasopharyngitis—Docetaxel—skin cancer	0.00265	0.00265	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Temozolomide—skin cancer	0.00263	0.00263	CcSEcCtD
Gallamine Triethiodide—Asthenia—Imiquimod—skin cancer	0.00263	0.00263	CcSEcCtD
Gallamine Triethiodide—Confusional state—Bleomycin—skin cancer	0.00262	0.00262	CcSEcCtD
Gallamine Triethiodide—Pruritus—Imiquimod—skin cancer	0.00259	0.00259	CcSEcCtD
Gallamine Triethiodide—Nausea—Vemurafenib—skin cancer	0.00255	0.00255	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Bleomycin—skin cancer	0.00255	0.00255	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Imiquimod—skin cancer	0.0025	0.0025	CcSEcCtD
Gallamine Triethiodide—Anaemia—Temozolomide—skin cancer	0.00248	0.00248	CcSEcCtD
Gallamine Triethiodide—Angioedema—Temozolomide—skin cancer	0.00246	0.00246	CcSEcCtD
Gallamine Triethiodide—Pancytopenia—Docetaxel—skin cancer	0.00244	0.00244	CcSEcCtD
Gallamine Triethiodide—Malaise—Temozolomide—skin cancer	0.00242	0.00242	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Temozolomide—skin cancer	0.00241	0.00241	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Dactinomycin—skin cancer	0.00237	0.00237	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00237	0.00237	CcSEcCtD
Gallamine Triethiodide—Cough—Temozolomide—skin cancer	0.00234	0.00234	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Bleomycin—skin cancer	0.00233	0.00233	CcSEcCtD
Gallamine Triethiodide—Vomiting—Imiquimod—skin cancer	0.00233	0.00233	CcSEcCtD
Gallamine Triethiodide—Rash—Imiquimod—skin cancer	0.00231	0.00231	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Imiquimod—skin cancer	0.00231	0.00231	CcSEcCtD
Gallamine Triethiodide—Headache—Imiquimod—skin cancer	0.00229	0.00229	CcSEcCtD
Gallamine Triethiodide—Anaemia—Fluorouracil—skin cancer	0.00229	0.00229	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Temozolomide—skin cancer	0.00229	0.00229	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.00227	0.00227	CcSEcCtD
Gallamine Triethiodide—Pain—Bleomycin—skin cancer	0.00222	0.00222	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Fluorouracil—skin cancer	0.00222	0.00222	CcSEcCtD
Gallamine Triethiodide—Confusional state—Temozolomide—skin cancer	0.00221	0.00221	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00221	0.00221	CcSEcCtD
Gallamine Triethiodide—Nausea—Imiquimod—skin cancer	0.00217	0.00217	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Temozolomide—skin cancer	0.00215	0.00215	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Bleomycin—skin cancer	0.00214	0.00214	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Temozolomide—skin cancer	0.00213	0.00213	CcSEcCtD
Gallamine Triethiodide—Chest pain—Fluorouracil—skin cancer	0.00211	0.00211	CcSEcCtD
Gallamine Triethiodide—Fatigue—Dactinomycin—skin cancer	0.00209	0.00209	CcSEcCtD
Gallamine Triethiodide—Pain—Dactinomycin—skin cancer	0.00207	0.00207	CcSEcCtD
Gallamine Triethiodide—Urticaria—Bleomycin—skin cancer	0.00207	0.00207	CcSEcCtD
Gallamine Triethiodide—Haemoglobin—Docetaxel—skin cancer	0.00206	0.00206	CcSEcCtD
Gallamine Triethiodide—Rhinitis—Docetaxel—skin cancer	0.00206	0.00206	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Bleomycin—skin cancer	0.00206	0.00206	CcSEcCtD
Gallamine Triethiodide—Haemorrhage—Docetaxel—skin cancer	0.00205	0.00205	CcSEcCtD
Gallamine Triethiodide—Hypoaesthesia—Docetaxel—skin cancer	0.00204	0.00204	CcSEcCtD
Gallamine Triethiodide—Confusional state—Fluorouracil—skin cancer	0.00204	0.00204	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Dactinomycin—skin cancer	0.002	0.002	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Temozolomide—skin cancer	0.002	0.002	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Fluorouracil—skin cancer	0.00198	0.00198	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Fluorouracil—skin cancer	0.00197	0.00197	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Temozolomide—skin cancer	0.00197	0.00197	CcSEcCtD
Gallamine Triethiodide—Eye disorder—Docetaxel—skin cancer	0.00192	0.00192	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Dactinomycin—skin cancer	0.00192	0.00192	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Dactinomycin—skin cancer	0.00192	0.00192	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Bleomycin—skin cancer	0.00192	0.00192	CcSEcCtD
Gallamine Triethiodide—Cardiac disorder—Docetaxel—skin cancer	0.00191	0.00191	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Temozolomide—skin cancer	0.00189	0.00189	CcSEcCtD
Gallamine Triethiodide—Fatigue—Temozolomide—skin cancer	0.00189	0.00189	CcSEcCtD
Gallamine Triethiodide—Pain—Temozolomide—skin cancer	0.00188	0.00188	CcSEcCtD
Gallamine Triethiodide—Asthenia—Bleomycin—skin cancer	0.00187	0.00187	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00184	0.00184	CcSEcCtD
Gallamine Triethiodide—Pruritus—Bleomycin—skin cancer	0.00184	0.00184	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Fluorouracil—skin cancer	0.00181	0.00181	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Temozolomide—skin cancer	0.00181	0.00181	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Dactinomycin—skin cancer	0.00179	0.00179	CcSEcCtD
Gallamine Triethiodide—Dysgeusia—Docetaxel—skin cancer	0.00175	0.00175	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Fluorouracil—skin cancer	0.00174	0.00174	CcSEcCtD
Gallamine Triethiodide—Urticaria—Temozolomide—skin cancer	0.00174	0.00174	CcSEcCtD
Gallamine Triethiodide—Asthenia—Dactinomycin—skin cancer	0.00174	0.00174	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Temozolomide—skin cancer	0.00173	0.00173	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Temozolomide—skin cancer	0.00173	0.00173	CcSEcCtD
Gallamine Triethiodide—Pain—Fluorouracil—skin cancer	0.00173	0.00173	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Fluorouracil—skin cancer	0.00167	0.00167	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Dactinomycin—skin cancer	0.00166	0.00166	CcSEcCtD
Gallamine Triethiodide—Vomiting—Bleomycin—skin cancer	0.00165	0.00165	CcSEcCtD
Gallamine Triethiodide—Anaemia—Docetaxel—skin cancer	0.00165	0.00165	CcSEcCtD
Gallamine Triethiodide—Rash—Bleomycin—skin cancer	0.00164	0.00164	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Bleomycin—skin cancer	0.00164	0.00164	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Temozolomide—skin cancer	0.00162	0.00162	CcSEcCtD
Gallamine Triethiodide—Urticaria—Fluorouracil—skin cancer	0.00161	0.00161	CcSEcCtD
Gallamine Triethiodide—Leukopenia—Docetaxel—skin cancer	0.0016	0.0016	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Fluorouracil—skin cancer	0.0016	0.0016	CcSEcCtD
Gallamine Triethiodide—Asthenia—Temozolomide—skin cancer	0.00157	0.00157	CcSEcCtD
Gallamine Triethiodide—Cough—Docetaxel—skin cancer	0.00156	0.00156	CcSEcCtD
Gallamine Triethiodide—Pruritus—Temozolomide—skin cancer	0.00155	0.00155	CcSEcCtD
Gallamine Triethiodide—Nausea—Bleomycin—skin cancer	0.00154	0.00154	CcSEcCtD
Gallamine Triethiodide—Vomiting—Dactinomycin—skin cancer	0.00154	0.00154	CcSEcCtD
Gallamine Triethiodide—Rash—Dactinomycin—skin cancer	0.00153	0.00153	CcSEcCtD
Gallamine Triethiodide—Arthralgia—Docetaxel—skin cancer	0.00152	0.00152	CcSEcCtD
Gallamine Triethiodide—Chest pain—Docetaxel—skin cancer	0.00152	0.00152	CcSEcCtD
Gallamine Triethiodide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.00151	0.00151	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Temozolomide—skin cancer	0.0015	0.0015	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Fluorouracil—skin cancer	0.00149	0.00149	CcSEcCtD
Gallamine Triethiodide—Confusional state—Docetaxel—skin cancer	0.00147	0.00147	CcSEcCtD
Gallamine Triethiodide—Nausea—Dactinomycin—skin cancer	0.00144	0.00144	CcSEcCtD
Gallamine Triethiodide—Pruritus—Fluorouracil—skin cancer	0.00143	0.00143	CcSEcCtD
Gallamine Triethiodide—Thrombocytopenia—Docetaxel—skin cancer	0.00143	0.00143	CcSEcCtD
Gallamine Triethiodide—Tachycardia—Docetaxel—skin cancer	0.00142	0.00142	CcSEcCtD
Gallamine Triethiodide—Skin disorder—Docetaxel—skin cancer	0.00142	0.00142	CcSEcCtD
Gallamine Triethiodide—Vomiting—Temozolomide—skin cancer	0.00139	0.00139	CcSEcCtD
Gallamine Triethiodide—Rash—Temozolomide—skin cancer	0.00138	0.00138	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Fluorouracil—skin cancer	0.00138	0.00138	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Temozolomide—skin cancer	0.00138	0.00138	CcSEcCtD
Gallamine Triethiodide—Headache—Temozolomide—skin cancer	0.00137	0.00137	CcSEcCtD
Gallamine Triethiodide—Musculoskeletal discomfort—Docetaxel—skin cancer	0.00133	0.00133	CcSEcCtD
Gallamine Triethiodide—Paraesthesia—Docetaxel—skin cancer	0.00131	0.00131	CcSEcCtD
Gallamine Triethiodide—Nausea—Temozolomide—skin cancer	0.0013	0.0013	CcSEcCtD
Gallamine Triethiodide—Vomiting—Fluorouracil—skin cancer	0.00128	0.00128	CcSEcCtD
Gallamine Triethiodide—Rash—Fluorouracil—skin cancer	0.00127	0.00127	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Fluorouracil—skin cancer	0.00127	0.00127	CcSEcCtD
Gallamine Triethiodide—Headache—Fluorouracil—skin cancer	0.00127	0.00127	CcSEcCtD
Gallamine Triethiodide—Gastrointestinal disorder—Docetaxel—skin cancer	0.00126	0.00126	CcSEcCtD
Gallamine Triethiodide—Fatigue—Docetaxel—skin cancer	0.00126	0.00126	CcSEcCtD
Gallamine Triethiodide—Pain—Docetaxel—skin cancer	0.00125	0.00125	CcSEcCtD
Gallamine Triethiodide—Feeling abnormal—Docetaxel—skin cancer	0.0012	0.0012	CcSEcCtD
Gallamine Triethiodide—Nausea—Fluorouracil—skin cancer	0.0012	0.0012	CcSEcCtD
Gallamine Triethiodide—Abdominal pain—Docetaxel—skin cancer	0.00115	0.00115	CcSEcCtD
Gallamine Triethiodide—Body temperature increased—Docetaxel—skin cancer	0.00115	0.00115	CcSEcCtD
Gallamine Triethiodide—Hypersensitivity—Docetaxel—skin cancer	0.00107	0.00107	CcSEcCtD
Gallamine Triethiodide—Asthenia—Docetaxel—skin cancer	0.00105	0.00105	CcSEcCtD
Gallamine Triethiodide—Pruritus—Docetaxel—skin cancer	0.00103	0.00103	CcSEcCtD
Gallamine Triethiodide—Diarrhoea—Docetaxel—skin cancer	0.000998	0.000998	CcSEcCtD
Gallamine Triethiodide—Vomiting—Docetaxel—skin cancer	0.000927	0.000927	CcSEcCtD
Gallamine Triethiodide—Rash—Docetaxel—skin cancer	0.00092	0.00092	CcSEcCtD
Gallamine Triethiodide—Dermatitis—Docetaxel—skin cancer	0.000919	0.000919	CcSEcCtD
Gallamine Triethiodide—Headache—Docetaxel—skin cancer	0.000914	0.000914	CcSEcCtD
Gallamine Triethiodide—Nausea—Docetaxel—skin cancer	0.000866	0.000866	CcSEcCtD
